The Retention Crisis
Why Keeping Patients in Treatment Is the Key to Saving Lives
January 27, 2026
The Crisis in Numbers
The opioid and stimulant use disorder crisis continues to devastate communities nationwide, claiming over 100,000 lives annually. According to 2023 data from the National Center for Drug Abuse Statistics, nearly 9 million Americans misused opioids during the year, and nearly 6 million qualified as having an opioid use disorder. For stimulants, 2.6 million people reported using methamphetamine and 5 million reported using cocaine. Nearly 1 in 5 drug overdose deaths were cocaine-related in 2023.
Medication-assisted treatment (MAT) works – but only if patients stay in treatment.
The Retention Problem
Traditional opioid use disorder (OUD) and Stimulant Use Disorder (StUD) programs face a revolving door challenge. Patients show up for their medication, receive minimal counseling to meet regulatory requirements, and leave. With this limited engagement, program retention becomes a major challenge that only increases over time.
The stark reality facing MAT providers is a retention crisis that worsens over time. According to Retention in Medication-Assisted Treatment for Opiate Dependence: A Systematic Review, by Timko et al, published in the Journal of Addictive Disease:
Ready to Improve Program Retention?
- 3 months: 19-94% retention
- 6 months: 3-88% retention
- 12 months: 37-91% retention
The variability in these numbers reveals a critical question: What separates programs achieving 91% retention from those struggling at 37%?
Why Retention Matters: The Life-or-Death Stakes
Retention isn’t just a performance metric – it’s a survival metric. The research is unequivocal:
- 50% reduction in mortality for patients receiving MAT versus untreated patients
- 3x lower mortality for patients retained more than 1 year versus those retained 1 year or less in treatment
Methadone has been shown to reduce opioid overdose deaths by 59%. A study of heroin-overdose deaths in Baltimore between 1995 and 2009 found an association between the increasing availability of methadone and buprenorphine had an approximately 50% decrease in the number of fatal overdoses.
The science is clear: staying in treatment for a minimum of 1 year saves lives.
The Challenge: Moving Beyond Transactional Care
Federal regulations require Opioid Treatment Programs (OTPs) to provide counseling and a range of assessment and treatment services. Each patient must have a treatment plan outlining requirements for education, vocational rehabilitation, employment, and other supportive services. Yet delivering this effectively at scale presents significant challenges.
While programs for StUD treatment face different regulatory requirements, both opioid and strimulant use treatment programs recognize that sustainable growth requires programs that combine medication management (where applicable) with behavioral health services, recovery support, and ongoing engagement throughout the treatment journey.
The Evidence-Based Solution: Contingency Management
Recovery incentives, also known as contingency management (CM) programs, represent one of the most powerful evidence-based interventions for substance use disorders, and is one of the most effective tools available for improving retention for those undergoing treatment for OUD or StUD.
Contingency management provides tangible rewards for positive behaviors, including medication adherence, negative drug screens, therapy attendance, and engagement in recovery activities.
The Evidence Is Compelling
Research demonstrates contingency management’s effectiveness for both opioid and stimulant use disorders:
- Increases treatment retention
- Reduces substance use
- Improves engagement in complementary therapies
For stimulant use disorder, where there are currently no FDA-approved medications, contingency management offers one of the few interventions with strong evidence backing it up. The Substance Abuse and Mental Health Services Administration (SAMHSA) recommends contingency management or recovery incentive rewards to support positive behavioral changes. In response to the evidence behind this intervention, in 2025 SAMHSA increased the allowable amount of incentives to $750 per patient per year.
Real-World Impact
The delivery of contingency management rewards for engagement with all facets of the program – MAT, behavioral health care, psychiatric care, and other components – greatly improves the odds that patients will remain in care. Patients who receive rewards achieve:
- Higher abstinence rates during treatment
- Longer retention in treatment
- Greater likelihood of remaining abstinent over time
As patients engage with additional services, clinical outcomes improve while maximizing legitimate reimbursement through the comprehensive delivery of billable services.
Digital Solutions Drive Measurable Improvements at Scale
Digital tools can be used to drive measurable improvements in retention, program adherence, clinical outcomes, and organizational performance across OTPs and StUD programs.
Recovery happens between clinic visits, not just during them. Traditional models provide limited support during the many hours each week patients aren’t at the dosing window. Digital platforms can extend the therapeutic relationship into daily life, providing continuous access to:
- Recovery support resources
- Peer support with 24/7 access
- Communication with the care team
- Incentives to drive retention
- Family support
Digital health tools offer treatment programs a new approach to delivering comprehensive therapeutic programs that address regulatory requirements, improve outcomes, and strengthen financial performance.
For treatment programs, this ongoing digital engagement strengthens treatment retention, which is the foundation of program sustainability. High retention reduces patient acquisition costs, increases lifetime value per patient, and creates stable census numbers that support operational planning and staffing decisions.
Digital platforms simplify recovery incentive programs by automating goal tracking, distributing incentives, and maintaining required documentation. This automation makes this approach practical at scale while ensuring program integrity.
Business Impact
The business impact is direct and measurable:
- Improved retention reduces costly patient churn and stabilizes census
- Increased therapy attendance generates additional billable counseling sessions within weekly bundles
- Enhanced medication adherence reduces medical complications and associated costs
- Better engagement in comprehensive services maximizes the reimbursement potential of bundled payments
- Documented outcomes support quality-based payment programs and competitive positioning
Ready to Improve Retention and Save Lives?
The data is clear: retention saves lives. For SUD treatment programs, the challenge isn’t just delivering evidence-based interventions like contingency management, it’s extending the therapeutic relationship beyond clinic visits to support patients during the critical hours when they’re navigating recovery on their own.
Digital tools make this possible by providing continuous access to recovery resources, peer support, educational content, care team communication, retention incentives, and family support – all essential to keeping patients engaged between appointments. This extended therapeutic relationship is what transforms transactional care into comprehensive treatment.
By strengthening patient engagement throughout the treatment journey, digital platforms drive measurable improvements in retention, clinical outcomes, and organizational performance. For programs committed to both clinical excellence and long-term sustainability, these tools aren’t just helpful—they’re critical to achieving sustained clinical outcomes and program success.
